Glypican 3 Expression in Urothelial Carcinoma: A Histopathological and Immunohistochemical Study
Introduction: Glypican 3 (GPC3) is an oncofetal protein, playing a role in cell regulation during fetal development, via Wingless/Integration (Wnt) signaling pathway. GPC3 immunohistochemical expression was detected in several tumours, most obvious in hepatocellular carcinoma. The GPC3 antibody is u...
Main Authors: | Solafa Amin Abd Al Aziz, Samia Mohamad Gabal, Wael Moustafa Mohamad, Sara Mohamad Abou Fandoud Mohamad |
---|---|
Format: | Article |
Language: | English |
Published: |
JCDR Research and Publications Private Limited
2019-02-01
|
Series: | Journal of Clinical and Diagnostic Research |
Subjects: | |
Online Access: | https://jcdr.net/articles/PDF/12593/39883_CE[Ra1]_F(SL)_PF1(AB_SL)_PN(SL).pdf |
Similar Items
-
Plasmocytoid urothelial carcinoma - clinical, histological, immunohistochemical and molecular aspects
by: Katia Ramos Moreira Leite
Published: (2020-01-01) -
Differential Immunohistochemical Profiles for Distinguishing Prostate Carcinoma and Urothelial Carcinoma
by: Woo Jin Oh, et al.
Published: (2016-09-01) -
Expression of selected pathway-marker genes in human urothelial cells exposed chronically to a non-cytotoxic concentration of monomethylarsonous acid
by: Matthew Medeiros, et al.
Published: (2014-01-01) -
WHO/ISUP classification of the urothelial tumors of the urinary bladder
by: Zdenka Ovčak
Published: (2005-09-01) -
Utility of p63 immunohistochemical stain in differentiating urothelial carcinomas from adenocarcinomas of prostate
by: Nasir Ud Din, et al.
Published: (2011-01-01)